mazdaki

CERS on Sell after the earnings call.

Viés de alta
NASDAQ:CERS   Cerus Corporation
1
I don't think the analyst have come to grasp the potential of this stock yet!. I have knowledge of the field and the FDA approvals should improve sales. Technically, we are still in the wedge and I think we will breakout of the wedge in the up side as opposed to the down so I will continue to accumulate as much as possible for the long term.
Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.